Cobianchi Stefano, Jaramillo Jessica, Luvisetto Siro, Pavone Flaminia, Navarro Xavier
Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.
Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.
Neuroscience. 2017 Sep 17;359:82-91. doi: 10.1016/j.neuroscience.2017.07.011. Epub 2017 Jul 14.
The injection of safe doses of botulinum neurotoxin A (BoNT/A) have been reported to be useful for the treatment of neuropathic pain, but it is still unknown how functional recovery is induced after peripheral nerve injury. We evaluated the effects of intranerve application of BoNT/A, on regeneration and sensorimotor functional recovery in partial and complete peripheral nerve injuries in the mouse. After sciatic nerve crush (SNC) and intranerve delivery of BoNT/A (15pg), axonal regeneration was measured by nerve pinch test at different days. Regeneration of myelinated and unmyelinated fibers was assessed by immunohistochemical double labeling for NF200/GAP43 and CGRP/GAP43. S100 was used as Schwann cells marker. Medial footpad skin reinnervation was assessed by PGP staining. Motor functions were assessed by means of nerve conduction tests. In other mice groups, nerve conduction tests were performed also after chronic constriction injury (CCI) of the sciatic nerve and intraplantar injection of BoNT/A (15pg). In SNC mice, BoNT/A increased the rate of axonal regeneration. The advantage of regrowing myelinated axons after BoNT/A injection was evidenced by longer NF200+ nerve profiles and confirmed by nerve histology. We observed also a higher expression of S100 in the distal portion of BoNT/A-injected regenerated nerves. In CCI mice, BoNT/A induced an increase in reinnervation of gastrocnemius and plantar muscles. These results show that a low dose of BoNT/A, insufficient to produce muscular dysfunction, conversely speeds up sensorimotor recovery by stimulating myelinated axonal regeneration, and points out its application as a multipotent treatment for peripheral neuropathies.
据报道,注射安全剂量的A型肉毒杆菌神经毒素(BoNT/A)可用于治疗神经性疼痛,但外周神经损伤后如何诱导功能恢复仍不清楚。我们评估了神经内应用BoNT/A对小鼠部分和完全外周神经损伤后再生及感觉运动功能恢复的影响。在坐骨神经挤压(SNC)并向神经内递送BoNT/A(15皮克)后,在不同天数通过神经夹捏试验测量轴突再生。通过对NF200/GAP43和CGRP/GAP43进行免疫组织化学双重标记来评估有髓和无髓纤维的再生。S100用作雪旺细胞标记物。通过PGP染色评估内侧足垫皮肤的再支配情况。通过神经传导测试评估运动功能。在其他小鼠组中,在坐骨神经慢性压迫损伤(CCI)并足底注射BoNT/A(15皮克)后也进行了神经传导测试。在SNC小鼠中,BoNT/A提高了轴突再生率。注射BoNT/A后有髓轴突再生的优势通过更长的NF200+神经轮廓得以证明,并经神经组织学证实。我们还观察到在注射BoNT/A的再生神经远端部分S100的表达更高。在CCI小鼠中,BoNT/A诱导腓肠肌和足底肌肉的再支配增加。这些结果表明,低剂量的BoNT/A不足以产生肌肉功能障碍,相反,它通过刺激有髓轴突再生加速感觉运动恢复,并指出其作为外周神经病变的多效性治疗方法的应用。